Comparison of Magnetic Resonance Imaging T2 Results in Beta-Thalassemia Patients Treated by Deferasirox or Combination of Deferoxamine and Deferiprone

نویسندگان
Vaseghi, Ghazal ID 1
Rashidbaghan, Azam ID 2
Vakili, Ali ID 3
Mirbehbahani, Narges Beygom ID 4
Jahazi, Azam ID 5

1 Hematology-Oncology Research Center, Taleghani Hospital, Golestan University of Medical Sciences, Gorgan, Iran

2 Kermanshah University of Medical Sciences, Kermanshah, Iran.

3 Golestan University of Medical Sciences, Gorgan, Iran

4 Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran

5 Gorgan Branch, Islamic Azad University, Gorgan, Iran

doi
10.18502/ijpho.v10i4.4407
چکیده

Background: Iron extra load is an anticipated and lethal consequence of chronic blood transfusion in major beta-thalassemia patients; therefore it is necessary to use an efficient iron chelator drug to stimulate the evacuation of the surplus iron from the body. This trial was performed to compare myocardial and hepatic magnetic ...

کلیدواژه‌ها
Beta-Thalassemia, Deferasirox, Deferiprone, Deferoxamine, Magnetic Resonance Imaging